Your Article Summary
XenoPort Appoints Dennis Fenton to Board
XenoPort, 08/14/09
XenoPort, Inc. announced the appointment of Dennis M. Fenton, Ph.D., to its board of directors. Dr. Fenton has over 30 years of pharmaceutical and biotechnology experience, including over 25 years at Amgen Inc., a biotechnology company.
Today in Execs on the Move...keeping you current
Receive free subspecialty "5-minute updates" via email
The Joint Commission Names Charles R. Buck to Board of Commissioners, Connie S. March to Represent Long Term Care Field
Joint Commission news, 12/07/09
Thomas H. Silberg to Retire as President and CEO of APP Pharmaceuticals, John Ducker Named as Successor
American Pharmaceutical Partners, 12/03/09
Cardinal Health names Carrie Cox to board of directors
Cardinal Health, 12/03/09
Article Search
Sponsor


See Latest Articles


